Gupta and colleagues36 were the first to report GLP-1 receptor expression in human hepatocytes and proposed that they play a direct role in reducing hepatic steatosis in vitro through the modulation of effectors of the insulin signaling pathway. This evidence concerns the gene GLP1R and Hepatic steatosis.